Literature DB >> 11434315

Conditional gene knockout using Cre recombinase.

Y Le, B Sauer.   

Abstract

Cre recombinase has become an important instrument for achieving precise genetic manipulation in mice. Many of these desired genetic manipulations rely on Cre's ability to direct spatially and temporally specified excision of a predesignated DNA sequence that has been flanked by directly repeated copies of the loxP recombination site. Success in achieving such conditional mutagenesis in mice depends both on the careful design of conditional alleles and on reliable detection of cre gene expression. These procedures include PCR, immunohistochemistry and the use of a recombination-proficient GFP-tagged Cre protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434315     DOI: 10.1385/MB:17:3:269

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  18 in total

1.  Site-specific insertion of DNA into a pseudorabies virus vector.

Authors:  B Sauer; M Whealy; A Robbins; L Enquist
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.

Authors:  M Lakso; J G Pichel; J R Gorman; B Sauer; Y Okamoto; E Lee; F W Alt; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Nuclear targeting determinants of the phage P1 cre DNA recombinase.

Authors:  Y Le; S Gagneten; D Tombaccini; B Bethke; B Sauer
Journal:  Nucleic Acids Res       Date:  1999-12-15       Impact factor: 16.971

4.  An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the beta-globin locus control region.

Authors:  S Fiering; C G Kim; E M Epner; M Groudine
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

5.  Identification of transgenic mice.

Authors:  M Gendron-Maguire; T Gridley
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

6.  Manipulation of transgenes by site-specific recombination: use of Cre recombinase.

Authors:  B Sauer
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

7.  Gene targeting in embryonic stem cells.

Authors:  R Ramírez-Solis; A C Davis; A Bradley
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

8.  Targeted oncogene activation by site-specific recombination in transgenic mice.

Authors:  M Lakso; B Sauer; B Mosinger; E J Lee; R W Manning; S H Yu; K L Mulder; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

9.  Brief expression of a GFP cre fusion gene in embryonic stem cells allows rapid retrieval of site-specific genomic deletions.

Authors:  S Gagneten; Y Le; J Miller; B Sauer
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

10.  Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting.

Authors:  H Gu; J D Marth; P C Orban; H Mossmann; K Rajewsky
Journal:  Science       Date:  1994-07-01       Impact factor: 47.728

View more
  16 in total

1.  A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration.

Authors:  Merhnaz Ghazvini; Wim Mandemakers; Martine Jaegle; Marko Piirsoo; Siska Driegen; Manousos Koutsourakis; Xsander Smit; Frank Grosveld; Dies Meijer
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

2.  Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development.

Authors:  Joy Lincoln; Ralf Kist; Gerd Scherer; Katherine E Yutzey
Journal:  Dev Biol       Date:  2007-02-07       Impact factor: 3.582

3.  Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage.

Authors:  Juanjuan Wang; Xueliang Xu; Michael H Elliott; Meili Zhu; Yun-Zheng Le
Journal:  Diabetes       Date:  2010-06-08       Impact factor: 9.461

4.  Generation and characterization of transgenic mice expressing tamoxifen-inducible cre-fusion protein specifically in mouse liver.

Authors:  Huan-Zhang Zhu; Jian-Quan Chen; Guo-Xiang Cheng; Jing-Lun Xue
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

5.  Transgenic mouse technology: principles and methods.

Authors:  T Rajendra Kumar; Melissa Larson; Huizhen Wang; Jeff McDermott; Illya Bronshteyn
Journal:  Methods Mol Biol       Date:  2009

6.  Positron emission tomography imaging of conditional gene activation in the heart.

Authors:  Gwendolen Y Chang; Feng Cao; Manickam Krishnan; Mei Huang; Zongjin Li; Xiaoyan Xie; Ahmad Y Sheikh; Grant Hoyt; Robert C Robbins; Tzung Hsiai; Michael D Schneider; Joseph C Wu
Journal:  J Mol Cell Cardiol       Date:  2007-03-24       Impact factor: 5.000

Review 7.  Experimental models of hepatocellular carcinoma.

Authors:  Philippa Newell; Augusto Villanueva; Scott L Friedman; Kazuhiko Koike; Josep M Llovet
Journal:  J Hepatol       Date:  2008-01-30       Impact factor: 25.083

8.  Generation and characterization of an Advillin-Cre driver mouse line.

Authors:  Sandra Zurborg; Agnieszka Piszczek; Conception Martínez; Philip Hublitz; Mumna Al Banchaabouchi; Pedro Moreira; Emerald Perlas; Paul A Heppenstall
Journal:  Mol Pain       Date:  2011-09-11       Impact factor: 3.395

9.  Postnatal liver growth and regeneration are independent of c-myc in a mouse model of conditional hepatic c-myc deletion.

Authors:  Jennifer A Sanders; Christoph Schorl; Ajay Patel; John M Sedivy; Philip A Gruppuso
Journal:  BMC Physiol       Date:  2012-03-07

10.  Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.

Authors:  Mohammed A Nassar; L Caroline Stirling; Greta Forlani; Mark D Baker; Elizabeth A Matthews; Anthony H Dickenson; John N Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.